This article was written at the end of last year prior to the recent IPO. One thing of interest is the 20 year sale agreement with Zimmer Biomet (market cap $24.55 Billion) and the worldwide distribution agreement with 3M ($126.05 Billion). I also note that there is a forecast of $20 million sales for 2019 which was not on the current prospectus for various reasons. But if the trajectory is true this would potentially represent revenue growth of over 600% vs 2018 revenue. DYOR and GLTAH!
- Forums
- ASX - By Stock
- NXS
- How the rich invest: Lang Walker backs Next Science's bacteria buster
How the rich invest: Lang Walker backs Next Science's bacteria buster
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $70.11M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.3¢ | $3.257K | 13.57K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6601 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 145820 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 17501 | 0.230 |
1 | 4545 | 0.220 |
1 | 25000 | 0.215 |
3 | 14448 | 0.205 |
1 | 20000 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 145820 | 2 |
0.295 | 3390 | 1 |
0.310 | 45789 | 1 |
0.330 | 180900 | 3 |
0.350 | 79920 | 3 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |